EI
Healthcare & Life Sciences
eTheRNA Immunotherapies
Belgium
eTheRNA Immunotherapies is a Healthcare & Life Sciences startup based in Belgium, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About eTheRNA Immunotherapies
Based in Belgium, eTheRNA Immunotherapies is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
eTheRNA Immunotherapies is a clinical-stage biotechnology company developing mRNA-based immunotherapies for cancer using its proprietary TriMix platform, which activates dendritic cells to induce antigen-specific T-cell responses against tumors.
Explore eTheRNA Immunotherapies's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.